News|Articles|December 2, 2021

Sartorius to Invest in Growing Operations in France

Sartorius is investing €100 million (US$113 million) between 2021 and 2025 to expand capacities for production, innovation, and storage at its French facilities in Aubagne, Cergy, and Lourdes.

Sartorius announced on Nov. 26, 2021 that it plans to invest a total of €100 million (US$113 million) between 2021 and 2025 to expand and upgrade its Aubagne, Cergy, and Lourdes facilities in France. The expansions will include:

  • An additional 4000 m2 of cleanroom space on top of the existing 5000 m2
  • The deployment of new R&D laboratories covering close to 2000 m2 to strengthen the company’s innovation capacity
  • An upgrade in the company’s logistics platforms and buildup of over 10,000 m2 of warehouse facilities and storage depots
  • The digitalization and automation of equipment to increase capacity and competitive advantage

The investment will enable Sartorius to further boost performance, increase its innovation, and meet growing market demand. Under its growth strategy, Sartorius will create up to 400 new permanent employment positions at the four French sites between 2021 and 2025. The company is seeking new talent in operations, such as production managers, machine operators, continuous improvement managers; product development staff, including engineers, data analysts; and marketing personnel. Sartorius will also support its teams by facilitating the acquisition of new, cutting-edge skills, particularly in automation and digitalization of equipment used in workflows.

“We see our biopharmaceutical customers entering a new phase characterized by a high pace of innovation, substantial investments in their operations, and increasing demands on us as their suppliers. We are supporting their efforts, significantly adding capacity and increasing the speed of delivery,” said Luc Burgard, managing director of Sartorius Stedim FMT and head of operations of the Bioprocess Solutions Division at Sartorius, in a company press release. “The investments in our French facilities will strengthen our industrial capabilities in this country and secure the long-term future of our operations here.”

Source: Sartorius


Related to this article

AAPS PharmSci 360 2026: Roller-Compacted Formulations
Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
Ask the Expert: Choosing Ingredient Suppliers
Jane Zhang of ETCH Sourcing explains why geopolitics, transparency, and partnership now weigh as heavily as cost and quality when companies choose suppliers, in this episode of Ask the Expert, moderated by Susan J. Schniepp of Nelson Labs.